JESSICA HARRIS: Open Payments
NPI 1083964951 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,137 in 140 payments from 19 companies in 2025. Trend: 2023 $1,349 · 2024 $1,829 · 2025 $2,137
Food & beverage: $2,137
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $579 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $240 |
| Phathom Pharmaceuticals, Inc. | 23 | $187 |
| Aimmune Therapeutics, Inc. | 10 | $185 |
| Madrigal Pharmaceuticals | 4 | $157 |
| Janssen Biotech, Inc. | 12 | $154 |
| Ardelyx, Inc. | 14 | $153 |
| Lilly USA, LLC | 5 | $88 |
| Gilead Sciences, Inc. | 3 | $54 |
| GENZYME CORPORATION | 2 | $54 |
Products named: RINVOQ, VOQUEZNA, SKYRIZI, REZDIFFRA, TREMFYA, IBSRELA, ENTYVIO, ZENPEP.
Industry payments across FL — which companies pay providers there.
